ASI Receives First and Only FDA CBER Cadaveric
Donor Clearance for Syphilis Screening
The United States Food and Drug Administration (FDA) grants CBER clearance for the first and only syphilis method
for the interpretation and screening of cadaveric (non-heart beating) donors using the ASI RPR Card Test
for Syphilis and the ASiManager-AT™ digital analyzer.
Arlington Scientific, in collaboration with the CDC, is developing three NEW fully automated nontreponemal EIA tests for the high throughput screening of syphilis.
Arlington Scientific is offering BETA TEST SITE OPPORTUNITIES to evaluate the automated EIA test.